China Pharmaceutical: Announcement of Resolutions of the 26th Meeting of the 9th Board of Directors
China Pharmaceutical: Assessment Report on the equity value assets of all shareholders of Beijing Jinsui Technology Development Co., Ltd. involved in the Beijing Jinsui Technology Development Co., Ltd. equity project held by China Healthcare Industry Co., Ltd. to acquire Beijing Jinsui Technology Development Co., Ltd. shares held by China Xinxing Group Co., Ltd.
China Pharmaceuticals: Announcement on the Company\'s Acquisition of Related Party Assets
China Pharmaceuticals: Beijing Jinsui Technology Development Co., Ltd. audit reports for 2024-1-6, 2023, 2022, and 2021
China Pharmaceutical: Beijing Jinsui Technology Development Co., Ltd. Audit Report for November 2021 to 2024
China Pharmaceutical: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2025
Beijing Jinsui Technology Development Co., Ltd. Audit Report for November 2021 to 2024
Evaluation report on the equity value assets of all shareholders of Beijing Jinsui Technology Development Co., Ltd. involved in the Beijing Jinsui Technology Development Co., Ltd. equity project held by China Healthcare Industry Co., Ltd. to acquire the shares of Beijing Jinsui Technology Development Co., Ltd. held by China Xinxing Group Co., Ltd.
Audit reports of Beijing Jinsui Technology Development Co., Ltd. from January to June 2024, 2023, 2022 and 2021
Announcement on the company\'s acquisition of related party assets
Announcement of Resolutions of the 26th Meeting of the 9th Board of Directors
Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2025
China Pharmaceutical: 2024 Annual General Meeting of Shareholders Meeting Information
2024 Annual General Meeting of Shareholders Meeting Materials
China Pharmaceuticals: Announcement on Subsidiary Pharmaceuticals Obtaining CEP Certificates
China Pharmaceuticals: Report for the first quarter of 2025
Announcement on the subsidiary\'s API obtaining the CEP certificate
2025 First Quarter Report
2024 Internal Control Audit Report
Announcement on the proposed registration of corporate bonds and ultra-short-term financing notes